Mayne Pharma | MYX - Net Income

Stock Price
2.69
Daily Change
0.06 2.28%
Monthly
14.47%
Yearly
-61.79%
Q2 Forecast
2.52

Mayne Pharma reported AUD-103.68M in Net Income for its fiscal semester ending in June of 2024.





Net Income Change Date
Ansell USD 88.8M 65.5M Dec/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Cochlear AUD 161.5M 69.6M Dec/2025
CSL USD 401M 96.5M Dec/2025
Healius AUD -12.8M 7.8M Dec/2024
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Medical Developments International AUD -226K 121K Dec/2025
Nanosonics AUD 9.64M 4.18M Dec/2025
Polynovo AUD 3K 9.87M Dec/2025
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
ResMed USD 392.59M 44.05M Dec/2025
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025